Article R5121-107-2 of the French Public Health Code
I.-The registration of the medicinal products mentioned in article L. 5121-13 may be refused, amended, suspended or withdrawn by the Director General of the Agency. The period of suspension may not exceed one year. Decisions to refuse, amend, suspend or cancel registration shall state the reasons on which they are based. They are notified to the applicant or registration holder and state the appeal procedures and deadlines applicable. Such decisions…